权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Characterization of Lphn3 function using a mutant murine model

使用突变小鼠模型表征 Lphn3 功能

基本信息

批准号：
8460516
负责人：
Deeann Wallis-Schultz
金额：
$ 15.82万
依托单位：
TEXAS A&M UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2012
资助国家：
美国
起止时间：
2012-04-20 至 2015-03-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8460516
关键词：
Adult Affect Anxiety Attention Attention deficit hyperactivity disorder Behavior Behavior assessment Behavioral Behavioral Assay Biological Assay Brain Brain region Candidate Disease Gene Cell Differentiation process Clinical Consumption Data Development Diagnosis Disease Dopamine Receptor Etiology G Protein-Coupled Receptor Genes Gene Expression Genes Genetic Polymorphism Genotype Glutamates Growth Image Impulsivity In Vitro Knockout Mice Learning Measures Memory Mental Depression Modeling Molecular Analysis Motivation Motor Motor Activity Mus Mutant Strains Mice Neurites Neuronal Differentiation Neurons Orphan Pathway interactions Pattern Pharmaceutical Preparations Pharmacogenetics Phenotype Play Reaction Time Research Reverse Transcriptase Polymerase Chain Reaction Role Seminal Series Serotonin Serotonin Receptor 5-HT2A Signal Transduction Sucrose Swimming System Testing Time Tissue-Specific Gene Expression addiction base design dopaminergic neuron gene function genome-wide linkage grasp human GPRC5C protein inattention male monoamine mutant neuron development neurotransmitter release novel receptor response serotonin receptor serotonin transporter

项目摘要

DESCRIPTION (provided by applicant): Though relatively unknown and uncharacterized, the orphan GPCR LPHN3 has already been correlated in genome-wide linkage and association studies to both addictive phenotypes and Attention Deficit Hyperactivity Disorder (ADHD) independently. Vulnerability to addiction and ADHD are frequently comorbid, suggesting a common etiology. Further, initial data indicate that LPHN3 genotype may be a pharmacogenetic marker predicting response to stimulant medication. Unfortunately, as no disease-associated functional polymorphisms have been identified in LPHN3, its mechanism of action is completely unknown, and further characterization of its function is essential as there are far reaching implications for such an important gene. The central hypothesis to be tested in this proposal is that Lphn3 signalling affects neurotransmitter release and concentrations of monoamines in the brain that may affect neural cell differentiation, development, and function. These alterations ultimately play out in an effect on basic behavior that may influence phenotypes such as ADHD and vulnerability to addiction. We propose to utilize the novel Lphn3 null mutant mouse to investigate gene function. Preliminary data indicate that the Lphn3 null mouse is hyperactive, has altered DA and 5-HT levels in the brain, and demonstrates altered expression levels of genes involved in neuronal differentiation and development as well as other ADHD candidate genes involving the dopaminergic and serotonergic pathways including dopamine and serotonin receptors. These scant clues have been used by us to construct our research plan. We will begin with defining the Lphn3 developmental expression pattern in the brain and look at co-expression with other well-characterized neuronal markers. We will also utilize TaqMan Gene Expression Assays to look for changes in expression of genes known to play a role in neuronal differentiation, development, survival, and function as a function of Lphn3 genotype. Assays will be preformed across developmental time points and in specific brain regions. Next we will isolate primary neurons from WT and mutant mice and evaluate their viability, growth and function based on Lphn3 genotype. Finally, we have designed a battery of behavioral assays to begin to evaluate the basic behavioral deficits in the Lphn3 mice. This battery includes preliminary assessment of: activity, motor function, anxiety, depression, motivation, attention, impulsivity, learning and memory. Data derived from this project will be a first step toward characterizing the basic functions of Lphn3, which could enable better understanding, diagnosis, and treatment of ADHD and addiction.

描述(由申请人提供)：虽然相对未知和没有特征，孤儿GPCRLPHN3已经在全基因组范围内与成瘾表型和注意缺陷多动障碍(ADHD)的关联研究中独立地被关联。容易上瘾和ADHD经常并存，这表明了共同的病因。此外，初步数据表明，LPHN3基因可能是预测刺激性药物反应的药物遗传学标志物。不幸的是，由于尚未在LPHN3中发现与疾病相关的功能多态性，其作用机制完全未知，因此对其功能的进一步鉴定是至关重要的，因为对如此重要的基因具有深远的影响。在这项提议中要检验的中心假设是，Lphn3信号影响神经递质的释放和大脑中单胺的浓度，这可能会影响神经细胞的分化、发育和功能。这些变化最终会对基本行为产生影响，这些行为可能会影响ADHD和成瘾易感性等表型。我们建议利用新的Lphn3缺失突变小鼠来研究基因功能。初步数据表明，Lphn3基因缺失的小鼠活动过度，改变了大脑中DA和5-羟色胺的水平，并表明参与神经元分化和发育的基因以及其他ADHD候选基因的表达水平发生了变化，这些基因涉及多巴胺和5-羟色胺能通路，包括多巴胺和5-羟色胺受体。这些稀少的线索被我们用来构建我们的研究计划。我们将从定义Lphn3在大脑中的发育表达模式开始，并观察与其他特征良好的神经元标记物的共同表达。我们还将利用TaqMan基因表达分析来寻找已知在神经元分化、发育、存活和作为Lphn3基因功能的功能中发挥作用的基因的表达变化。化验将在发育时间点和特定的大脑区域进行。接下来，我们将从WT和突变小鼠中分离出原代神经元，并基于Lphn3基因来评估它们的活性、生长和功能。最后，我们设计了一系列行为测试，开始评估Lphn3小鼠的基本行为缺陷。该组合包括：活动、运动功能、焦虑、抑郁、动机、注意力、冲动、学习和记忆的初步评估。来自该项目的数据将是表征Lphn3基本功能的第一步，这将使人们能够更好地理解、诊断和治疗ADHD和成瘾。